Maureen Donahue Hardwick

Maureen Donahue Hardwick concentrates her practice on the formation and management of focused industry consortia that address common scientific, regulatory and policy goals of pharmaceutical, biotechnology and medical device companies.

Maureen’s practice includes serving as secretariat and legal counsel for several pharmaceutical consortia addressing a range of compliance matters affecting the pharmaceutical and health care industry in the U.S., the EU and other countries around the world. She represents a consortium of multinational pharmaceutical companies manufacturing asthma therapies that rely on propellants subject to regulation under the Montreal Protocol and Kyoto Protocol. In this capacity, she has represented the consortium before international environmental bodies and has also periodically coordinated efforts of the consortium with patient advocacy groups.